Page last updated: 2024-08-23

miglustat and Weight Reduction

miglustat has been researched along with Weight Reduction in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gianutsos, J; Kolodny, EH; Luzy, C; Pastores, GM; Shapiro, BE	1
Alfonso, P; Alonso, D; Atutxa, K; Barez, A; Fernández-Galán, MA; Franco, R; Giraldo, P; Latre, P; Martin, A; Pocovi, M	1
Abel, L; Chadha-Boreham, H; Giorgino, R; Jacklin, E; Luzy, C; Patterson, MC; Vecchio, D; Wraith, JE	1
Champion, H; Cox, TM; Gallagher, J; Imrie, J; Lachmann, RH; Ramaswami, U; Wraith, JE	1
Butters, TD; Dwek, RA; Platt, FM; Priestman, DA; van der Spoel, AC	1

Trials

3 trial(s) available for miglustat and Weight Reduction

Article	Year
Miglustat in late-onset Tay-Sachs disease: a 12-month, randomized, controlled clinical study with 24 months of extended treatment. Genetics in medicine : official journal of the American College of Medical Genetics, 2009, Volume: 11, Issue:6 Topics: 1-Deoxynojirimycin; Adolescent; Adult; Age of Onset; Diarrhea; Enzyme Inhibitors; Fatigue; Female; Glycoside Hydrolase Inhibitors; Humans; Male; Middle Aged; Tay-Sachs Disease; Time Factors; Treatment Outcome; Weight Loss; Young Adult	2009
Real-world clinical experience with long-term miglustat maintenance therapy in type 1 Gaucher disease: the ZAGAL project. Haematologica, 2009, Volume: 94, Issue:12 Topics: 1-Deoxynojirimycin; Adolescent; Adult; Chemokines, CC; Child; Enzyme Inhibitors; Female; Gaucher Disease; Glycoside Hydrolase Inhibitors; Hexosaminidases; Humans; Liver; Male; Middle Aged; Organ Size; Prospective Studies; Quality of Life; Spleen; Surveys and Questionnaires; Time Factors; Treatment Outcome; Weight Loss; Young Adult	2009
Miglustat in adult and juvenile patients with Niemann-Pick disease type C: long-term data from a clinical trial. Molecular genetics and metabolism, 2010, Volume: 99, Issue:4 Topics: 1-Deoxynojirimycin; Adolescent; Adult; Child; Deglutition; Diarrhea; Female; Humans; Niemann-Pick Disease, Type C; Walking; Weight Loss	2010

Other Studies

2 other study(ies) available for miglustat and Weight Reduction

Article	Year
Dietary modifications in patients receiving miglustat. Journal of inherited metabolic disease, 2010, Volume: 33 Suppl 3 Topics: 1-Deoxynojirimycin; Adolescent; Adolescent Development; Adult; Age Factors; Child; Child Development; Diet, Carbohydrate-Restricted; England; Enzyme Inhibitors; Gastrointestinal Diseases; Glucosyltransferases; Humans; Lactose; Lysosomal Storage Diseases, Nervous System; Retrospective Studies; Time Factors; Treatment Outcome; Weight Loss; Young Adult	2010
N-butyldeoxynojirimycin causes weight loss as a result of appetite suppression in lean and obese mice. Diabetes, obesity & metabolism, 2008, Volume: 10, Issue:2 Topics: 1-Deoxynojirimycin; Adipose Tissue; Animals; Appetite Regulation; Enzyme Inhibitors; Leptin; Mice; Mice, Obese; Obesity; Weight Loss	2008

Article

Year

Dietary modifications in patients receiving miglustat.

Journal of inherited metabolic disease, 2010, Volume: 33 Suppl 3

Topics: 1-Deoxynojirimycin; Adolescent; Adolescent Development; Adult; Age Factors; Child; Child Development; Diet, Carbohydrate-Restricted; England; Enzyme Inhibitors; Gastrointestinal Diseases; Glucosyltransferases; Humans; Lactose; Lysosomal Storage Diseases, Nervous System; Retrospective Studies; Time Factors; Treatment Outcome; Weight Loss; Young Adult

2010

N-butyldeoxynojirimycin causes weight loss as a result of appetite suppression in lean and obese mice.

Diabetes, obesity & metabolism, 2008, Volume: 10, Issue:2

Topics: 1-Deoxynojirimycin; Adipose Tissue; Animals; Appetite Regulation; Enzyme Inhibitors; Leptin; Mice; Mice, Obese; Obesity; Weight Loss

2008